ArticleOncoimmunology2020

Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition.

Victor Cervera-Carrascon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.